Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2010
07/14/2010CN101138556B Terbinafine or its salt film forming gel composition and uses thereof
07/14/2010CN101134056B Traditional Chinese medicine for preventing and treating baraquet and method of making the same
07/14/2010CN101130085B Nano montmorillonite for restraining bacterium and method of preparing the same
07/14/2010CN101129473B Radix fici simplicissimatis extractive and method of producing the same and use thereof
07/14/2010CN101077362B Plant-type skin mucosa disinfecting agent
07/13/2010US7754855 comprising a full-length human erythropoietin protein joined without an intervening peptide linker to a human immunoglobulin domain; making fusion proteins comprising a cytokine or growth factor fused to an immunoglobulin domain; treating deficient hematocrit; purification
07/13/2010US7754774 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
07/13/2010US7754769 reducing pro-inflammatory response in diseased cell of respiratory tract by contacting cell with an agent that increases ceramide levels in cell thereby reducing pro-inflammatory response in cell, wherein agent is fenretinide and diseased cell is representative of disease state of cystic fibrosis
07/13/2010US7754751 Preferential inhibition of release of pro-inflammatory cytokines
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754728 Adenine compound and use thereof
07/13/2010US7754682 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
07/13/2010US7754676 Cancer and viral infections vaccines; increased immunogenicity
07/13/2010US7754449 Human papilloma virus treatment
07/13/2010US7754430 Papilloma virus capsomere vaccine formulations and methods of use
07/13/2010US7754240 Solid at ambient temperature, softening point of </= 35 degrees C., when placed in continuous contact with skin it is softened to a consistency so substantial application of the unit dose is delivered in < 10 minutes
07/13/2010US7754219 by binding a target antigen (such as a protein) to a transport factor that contains a fragment of a bipartite protein exotoxin, but not the corresponding protective antigen
07/13/2010US7754218 Vaccines comprising aluminum adjuvants and histidine
07/13/2010CA2567916C Method for producing antibiotic / antibiotics - particles and their use
07/13/2010CA2448303C Biologically active methylene blue derivatives
07/13/2010CA2446820C Novel pyrrole derivatives as pharmaceutical agents
07/13/2010CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
07/13/2010CA2427837C Radioactive member for use in brachytherapy and method of making
07/13/2010CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/13/2010CA2324289C Combined vaccine compositions
07/13/2010CA2297345C Novel antigenic class of avian reoviruses
07/13/2010CA2262893C Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
07/09/2010CA2648602A1 Method of treating pregnant cows and/or heifers
07/08/2010WO2010078518A1 Anti-herpes simplex virus antibodies and methods of use thereof
07/08/2010WO2010077783A1 Hepatitis c virus inhibitors
07/08/2010WO2010077740A2 Novel antiviral compounds, compositions, and methods of use
07/08/2010WO2010077734A2 Novel antiviral compounds, compositions, and methods of use
07/08/2010WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010WO2010077682A2 Treatment of hiv and aids using probiotic lactobacillus reuteri
07/08/2010WO2010077613A1 Modulators of toll-like receptors
07/08/2010WO2010077317A2 Protease inhibitors
07/08/2010WO2010077061A2 Pharmaceutical formulations containing antiviral drugs
07/08/2010WO2010076851A1 Therapeutic/prophylactic agent for infections which relies on regulation of il-17a/il-17f
07/08/2010WO2010076730A1 Method for the treatment of an hiv infection
07/08/2010WO2010076618A1 Combination gas vaccines and therapeutics
07/08/2010WO2010076323A1 Use of ammonium chloride in therapy
07/08/2010WO2010075962A1 Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof
07/08/2010WO2010075861A2 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
07/08/2010WO2010075801A1 Pharmaceutical formulations comprising voriconazole and processes for preparation thereof
07/08/2010WO2010075765A1 Cefdinir acid double salt and its preparation
07/08/2010WO2010075665A1 A formulation of silibinin with high efficiency and prolonged action and the preparation method thereof
07/08/2010WO2010075663A1 A formulation of silymarin with high efficiency and prolonged action and the preparation method thereof
07/08/2010WO2010075636A1 Compounds and methods for treatment of influenza
07/08/2010WO2010056633A3 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
07/08/2010WO2010051634A9 Human progenitor t-cells
07/08/2010WO2010051541A3 Compositions containing delta-9-thc-amino acid esters and process of preparation
07/08/2010WO2010041938A3 New virulence factors of streptococcus pneumoniae
07/08/2010WO2010041143A3 Oral vaccines for producing mucosal immunity
07/08/2010WO2010019698A3 Inhibition of calicivirus (norovirus)
07/08/2010US20100174222 Method and apparatus for acne treatment using low intensity light therapy
07/08/2010US20100174076 Coumarin derivatives useful as tnf alpha inhibitors
07/08/2010US20100173991 Method for the synthesis of a-ring aromatized acetyl minocyclines
07/08/2010US20100173980 Antiviral oligonucleotides targeting rsv
07/08/2010US20100173944 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
07/08/2010US20100173939 Antiviral compounds
07/08/2010US20100173933 Antibacterial agents
07/08/2010US20100173929 Tricyclic N-heteroaryl-carboxamide derivatives, preparation and therapeutic use thereof
07/08/2010US20100173921 Antiretroviral Solid Oral Composition
07/08/2010US20100173909 Piperidine compounds and uses thereof - 596
07/08/2010US20100173906 Substituted 3,4,6,7-Tetrahydro-5H-1,2a,4a,8-Tetraazacyclopenta[cd]Phenalenes and Methods
07/08/2010US20100173904 Topical composition, topical composition precursor, and methods for manufacturing and using
07/08/2010US20100173895 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose)polymerase(parp)
07/08/2010US20100173887 Bactericidal anti-mrsa active pharmaceutical composition containing carbapenems
07/08/2010US20100173870 Phosphonate Compounds
07/08/2010US20100173863 2-Fluoronucleosides
07/08/2010US20100173862 Injectable, injection solution, and injection kit preparation
07/08/2010US20100173858 Compositions to treat bacterial and inflammatory affections in pet animals dosage form and method to treat pet animals
07/08/2010US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
07/08/2010US20100173848 Methods of inhibiting chemokine binding to chemokines receptors
07/08/2010US20100173845 Use of fertirelin and delta-endorphin as therapeutic agents
07/08/2010US20100173842 Vaccine for staphylococcal infections
07/08/2010US20100173838 Novel process for the preparation of cyclosporin derivatives
07/08/2010US20100173837 Dosing forms and regimens comprising 3-[(r)-2-(n,n-dimethylamino)ethylthio-sar]-4-(gammahydroxymethylleucine)cyclosporine
07/08/2010US20100173836 Novel macrocycles
07/08/2010US20100173833 Methods and composition for use of cyclic analogues of histatin
07/08/2010US20100173827 Role of proline rich peptides in cellular communication mechanisms and treatment of diseases
07/08/2010US20100173779 Composition and method to stimulate growth and defense against pathogens in plants
07/08/2010US20100173388 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
07/08/2010US20100173020 Uses of ammonium chloride
07/08/2010US20100173017 Method of manufacturing skin care cream containing baked shell powder
07/08/2010US20100172993 Particles for delivery of active ingredients, process of making and compositions thereof
07/08/2010US20100172992 Pathogenic attenuation via the administration of an equilibiotic compound
07/08/2010US20100172976 Methods and compositions for inhibiting the function of polynucleotide sequences
07/08/2010US20100172970 Dosage forms made by melt extrusion with water soluble polymer to improve bioavailability; once daily oral dosage form; antivirals such as 4-[[4-amino-5-chloro-6-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzonitrile for treating non-nucleoside reverse transcriptase inhibitor resistant HIV
07/08/2010US20100172966 Methods and compositions for cellular reprogramming
07/08/2010US20100172938 Modified bacterial surface layer proteins
07/08/2010US20100172937 Enveloped virus neutralizing compounds
07/08/2010US20100172936 Chimeric papillomavirus-like particles
07/08/2010US20100172935 Method for viral inoculation of the vestibular region of the nares
07/08/2010US20100172933 Recombinant vectors based on the modified vaccinia ankara (mva) virus as vaccines against lieshmaniasis
07/08/2010US20100172932 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes
07/08/2010US20100172931 Pharmaceutical Composition Containing the NMB1796 Protein
07/08/2010US20100172927 Vaccines Against Chlamydial Infection
07/08/2010US20100172926 Anthrax compositions and methods of use and production
07/08/2010US20100172922 Expression and Purification of HIP/PAP and Uses Therefor